CC - CIK 0001627223
The table below shows Chemours Co's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $264.00M | -$633.00M | $556.00M | $755.00M | $814.00M | $807.00M |
| Capital expenditure | $213.00M | $360.00M | $370.00M | $307.00M | $277.00M | $267.00M |
| Investing cash flow | -$206.00M | -$353.00M | -$229.00M | -$284.00M | $220.00M | -$234.00M |
| Dividends paid | - | - | - | - | - |
Chemours Co reported operating cash flow of $264.00M for fiscal year 2025. That is up 141.7% from -$633.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $594.00M (FY 2016) to $264.00M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | $69.00M | $495.00M | $173.00M | $0.00 |
| Financing cash flow | -$126.00M | -$36.00M | $172.00M | -$686.00M | -$554.00M | -$449.00M |